Evidence map›Paper›PMID 21122961›Full record

Trial reportAmerican journal of kidney diseases : the official journal of the National Kidney Foundation2011

Baseline characteristics of participants in the Frequent Hemodialysis Network (FHN) daily and nocturnal trials.

Michael V Rocco, Brett Larive, Paul W Eggers, Gerald J Beck, Glenn M Chertow, Nathan W Levin, Alan S Kliger, FHN Trial Group

Registry-linked trialAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in American journal of kidney diseases : the official journal of the National Kidney Foundation, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00264758 (Frequent Hemodialysis Network), which is not on this map. Cited by 23 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 3 pooled it
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00264758 phase2 / phase3completednot on this map

Frequent Hemodialysis Network: Daily Trial

TypeinterventionalSponsorNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Ran2006 to 2010Enrolled245ConditionsEnd Stage Renal DiseaseArmsConventional hemodialysis, Frequent hemodialysis
3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 3 syntheses or guidelines pooled it, 48 citations in OpenAlex.

  1. Interventions for fatigue in people with kidney failure requiring dialysis.The Cochrane database of systematic reviews · 2023
    Pooled it
  2. Pooled it
  3. Home versus in-centre haemodialysis for end-stage kidney disease.The Cochrane database of systematic reviews · 2014
    Pooled it
  4. Trial
  5. Long-Term Effects of Frequent In-Center Hemodialysis.Journal of the American Society of Nephrology : JASN · 2016
    Trial
  6. The effect of frequent hemodialysis on self-reported sleep quality: Frequent Hemodialysis Network Trials.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2016
    Trial
  7. Long-term Effects of Frequent Nocturnal Hemodialysis on Mortality: The Frequent Hemodialysis Network (FHN) Nocturnal Trial.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2015
    Trial
  8. Effects of frequent hemodialysis on blood pressure: Results from the randomized frequent hemodialysis network trials.Hemodialysis international. International Symposium on Home Hemodialysis · 2015
    Trial
  9. Trial
  10. Effects of frequent hemodialysis on ventricular volumes and left ventricular remodeling.Clinical journal of the American Society of Nephrology : CJASN · 2013
    Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Article
  17. Article
  18. Article
  19. Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 1 country.

Michael V RoccoDepartment of Medicine, Wake Forest University School of Medicine, Winston-Salem, NC 27157-1053, USA. mrocco@wfubmc.edu
Brett Larive
Paul W Eggers
Gerald J Beck
Glenn M Chertow
Nathan W Levin
Alan S Kliger
FHN Trial Group
Cleveland Clinic · USNational Institute of Diabetes and Digestive and Kidney Diseases · USRenal Research Institute · USStanford University · USWake Forest University · USYale New Haven Hospital · US

Funding

Frequent Hemodialysis Network Data Coordinating CenterU01DK066597 · NIDDK · CLEVELAND CLINIC LERNER COM-CWRU · PI BECK, GERALD J · 2003 to 2010
$8.9M
Frequent Hemodialysis Network - West Coast ConsortiumU01DK066481 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHERTOW, GLENN MATTHEW · 2003 to 2010
$5.2M
The Short-Daily Hemodialysis Pilot StudyU01DK066579 · NIDDK · RENAL RESEARCH INSTITUTE, LLC · PI LEVIN, NATHAN W · 2003 to 2010
$5.0M
Frequent Hemodialysis Network (FHN) - Nocturnal Clinical Core ConsortiumU01DK066480 · NIDDK · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ROCCO, MICHAEL V · 2003 to 2010
$3.7M
NIDDK NIH HHS 2U01DK066579NIDDK NIH HHS 3U01DK066480NIDDK NIH HHS 3U01DK066481NIDDK NIH HHS U01 DK066480NIDDK NIH HHS U01 DK066481NIDDK NIH HHS U01 DK066579NIDDK NIH HHS U01 DK066597NIDDK NIH HHS U01DK066597
6 · The paper itself

Abstract

backgroundThe annual mortality rate for maintenance hemodialysis patients in the United States is unacceptably high at 15%-20%. In 2004, we initiated the Frequent Hemodialysis Network (FHN) clinical trials. This report presents baseline characteristics of FHN Trial participants and compares them with hemodialysis patients tracked in US Renal Data System (USRDS) data. STUDY

design2 separate randomized clinical trials. SETTINGS &

participantsFHN includes 332 patients with chronic kidney disease requiring long-term dialysis therapy enrolled in 2 separate randomized clinical trials. The FHN Daily Trial (245 randomly assigned participants) was designed to compare outcomes of 6-times-weekly in-center daily hemodialysis (1.5-2.75 h/session) with conventional 3-times-weekly in-center hemodialysis. The FHN Nocturnal Trial (87 randomly assigned participants) was designed to compare outcomes of 6-times-weekly home nocturnal (6-8 h/session) with conventional 3-times-weekly hemodialysis. USRDS data include 338,109 incident and prevalent long-term hemodialysis patients from the calendar year 2007.

resultsParticipants in both trials were on average younger than the average hemodialysis patient in the United States (Daily Trial, 50.4 years; P < 0.001; Nocturnal Trial, 52.8 years; P < 0.001). Compared with USRDS data, whites were under-represented in the Daily Trial (36% vs 55%; P < 0.001), whereas Hispanics were under-represented in the Nocturnal Trial and over-represented in the Daily Trial (0% vs 28%; P < 0.001). In addition, there were more fistulas and fewer catheters in the Daily Trial (61% and 20%, respectively; P < 0.001 for both) and fewer grafts and more catheters in the Nocturnal Trial (10% and 44%, respectively; P < 0.005 for both). LIMITATIONS: Clinical trial exclusion criteria and patient willingness to participate limit comparisons with the USRDS.

conclusionsFHN participants were younger and the racial composition for each study was different from the racial composition of the aggregate US dialysis population. Catheters for vascular access were more common in FHN Nocturnal Trial participants.

Indexed as

FemaleHemodialysis, HomeHumansKidney Failure, ChronicMaleMiddle AgedRenal DialysisSocioeconomic FactorsUnited States

Identifiers

PMID21122961
PMCPMC3058226
OpenAlexW2056579542

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.